Literature DB >> 28422785

Role of nonneutralizing antibodies in vaccines and/or HIV infected individuals.

Luzia Mayr1, Bin Su, Christiane Moog.   

Abstract

PURPOSE OF REVIEW: Increased body of evidence gathered over time indicate that antibodies are capable of many inhibitory mechanisms, virus neutralization being just one of them. Nonneutralizing antibodyactivities interfering with HIV replication can also lead to a decrease in viral load and even in-vivo protection. RECENT
FINDINGS: It was previously believed that neutralizing antibodies can achieve sterilizing protection mainly by using their neutralization capacities against the infecting virus directly at the portal of virus entry. Recent findings show that protection can be obtained by neutralizing antibodiesat distal sites of virus challenge. In this case, foci of virus infection that escaped from initial inhibition of virus are eliminated presumably by additional nonneutralizing antibody activities. These data inexorably strengthen the diverse functions of antibodies and broaden their role as antiviral mediator.
SUMMARY: The review summarizes the current knowledge and the difficulties to encompass the numerous functions of antibodies. A complete understanding of the various facets of antibody functions is required to efficiently induce them via next-generation vaccine design.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28422785     DOI: 10.1097/COH.0000000000000357

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  6 in total

1.  Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent.

Authors:  Blandine Noailly; Melyssa Yaugel-Novoa; Justine Werquin; Fabienne Jospin; Daniel Drocourt; Thomas Bourlet; Nicolas Rochereau; Stéphane Paul
Journal:  Vaccines (Basel)       Date:  2022-06-06

Review 2.  Lessons learned from human HIV vaccine trials.

Authors:  Justin Pollara; David Easterhoff; Genevieve G Fouda
Journal:  Curr Opin HIV AIDS       Date:  2017-05       Impact factor: 4.283

Review 3.  Non-Neutralizing Antibodies Directed against HIV and Their Functions.

Authors:  Luzia M Mayr; Bin Su; Christiane Moog
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

Review 4.  Antibody responses to viral infections: a structural perspective across three different enveloped viruses.

Authors:  Charles D Murin; Ian A Wilson; Andrew B Ward
Journal:  Nat Microbiol       Date:  2019-03-18       Impact factor: 17.745

Review 5.  Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.

Authors:  Bin Su; Stefania Dispinseri; Valeria Iannone; Tong Zhang; Hao Wu; Raphael Carapito; Seiamak Bahram; Gabriella Scarlatti; Christiane Moog
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

6.  Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors.

Authors:  Mehmet Sahin; Melissa M Remy; Benedict Fallet; Rami Sommerstein; Marianna Florova; Anna Langner; Katja Klausz; Tobias Straub; Mario Kreutzfeldt; Ingrid Wagner; Cinzia T Schmidt; Pauline Malinge; Giovanni Magistrelli; Shozo Izui; Hanspeter Pircher; J Sjef Verbeek; Doron Merkler; Matthias Peipp; Daniel D Pinschewer
Journal:  Cell Rep       Date:  2022-02-01       Impact factor: 9.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.